tirzepatide health risks Long-Term Safety of Tirzepatide: What Research and Experts Reveal Tirzepatide Side Effects: Full Guide
Description
Service GJ, Thompson GB, Service FJ, Andrews JC, Collazo-Clavell ML, Lloyd RV
Tirzepatide medication is typically prescribed for the treatment of type II diabetes
Tirzepatide (Mounjaro) produces up to 22.5% average body weight loss over 72 weeks in the SURMOUNT-1 trial
Serious but Rare Side Effects More serious complications occur in less than 1% of patients but require immediate medical attention
Patient Preferences Considering factors such as ease of use, injection site preferences, and lifestyle compatibility to enhance treatment satisfaction and promote sustained adherence
